CA2142811A1 - Methode de preparation d'un nouveau glucane - Google Patents

Methode de preparation d'un nouveau glucane

Info

Publication number: CA2142811A1
Authority: CA; Canada
Prior art keywords: beta; neutral; glucan; aqueous soluble; glucans
Prior art date: 1992-08-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

CA002142811A

Other languages

English (en)

Other versions

CA2142811C (fr

Inventor

Spiros Jamas

D. Davidson Easson, Jr.

Gary R. Ostroff

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Collaborative Group Ltd

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-08-21

Filing date

1993-08-20

Publication date

1994-03-03

1992-08-21 Priority claimed from US07/934,015 external-priority patent/US5622939A/en

1993-08-20 Application filed by Individual filed Critical Individual

1994-03-03 Publication of CA2142811A1 publication Critical patent/CA2142811A1/fr

2006-10-31 Application granted granted Critical

2006-10-31 Publication of CA2142811C publication Critical patent/CA2142811C/fr

2013-08-20 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

229920001503 Glucan Polymers 0.000 title abstract 8
238000002360 preparation method Methods 0.000 title abstract 4
238000004519 manufacturing process Methods 0.000 abstract 4
230000007935 neutral effect Effects 0.000 abstract 4
108010002352 Interleukin-1 Proteins 0.000 abstract 2
230000000694 effects Effects 0.000 abstract 2
230000001900 immune effect Effects 0.000 abstract 2
210000001616 monocyte Anatomy 0.000 abstract 2
230000004936 stimulating effect Effects 0.000 abstract 2
108090000695 Cytokines Proteins 0.000 abstract 1
102000004127 Cytokines Human genes 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
206010037660 Pyrexia Diseases 0.000 abstract 1
210000001772 blood platelet Anatomy 0.000 abstract 1
230000001627 detrimental effect Effects 0.000 abstract 1
230000002607 hemopoietic effect Effects 0.000 abstract 1
230000028993 immune response Effects 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
230000003641 microbiacidal effect Effects 0.000 abstract 1
210000000440 neutrophil Anatomy 0.000 abstract 1
210000001539 phagocyte Anatomy 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Materials Engineering (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Polymers & Plastics (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CA002142811A 1992-08-21 1993-08-20 Methode de preparation d'un nouveau glucane Expired - Lifetime CA2142811C (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US07/934,015		1992-08-21
US07/934,015 US5622939A (en)	1992-08-21	1992-08-21	Glucan preparation
PCT/US1993/007904 WO1994004163A1 (fr)	1992-08-21	1993-08-20	Nouvelle preparation de glucanes

Publications (2)

Publication Number	Publication Date
CA2142811A1 true CA2142811A1 (fr)	1994-03-03
CA2142811C CA2142811C (fr)	2006-10-31

Family

ID=26786977

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002142811A Expired - Lifetime CA2142811C (fr)	1992-08-21	1993-08-20	Methode de preparation d'un nouveau glucane

Country Status (2)

Country	Link
CA (1)	CA2142811C (fr)
NO (1)	NO950634L (fr)

1993
- 1993-08-20 CA CA002142811A patent/CA2142811C/fr not_active Expired - Lifetime
1995
- 1995-02-20 NO NO950634A patent/NO950634L/no unknown

Also Published As

Publication number	Publication date
NO950634L (no)	1995-04-20
NO950634D0 (no)	1995-02-20
CA2142811C (fr)	2006-10-31

Similar Documents

Publication	Publication Date	Title
AU4095397A (en)	1997-12-18	Novel glucan preparation
ES2060158T3 (es)	1994-11-16	Uso de alcoholes alifaticos c-22 a c-26 en el tratamiento de enfermedades de la piel inflamatorias y viricas.
ZA922826B (en)	1993-04-16	Sun filter microcapsules, their preparation process, the cosmetic and pharmaceutical compositions containing them and their uses.
PT656061E (pt)	2004-03-31	Novas glicoformas do receptor do complemento 1 soluvel
CA2158475A1 (fr)	1994-09-29	Composition et methode pour la reduction de facteurs biologiquement actifs
EP0763362A3 (fr)	1998-04-08	Base pharmaceutique en forme de pommade et son utilisation
CA2090650A1 (fr)	1993-09-03	Methode de production d'un inhibiteur de la voie de synthese d'un facteur tissulaire
AU5061190A (en)	1990-09-06	Novel benzimidazole and azabenzimidazole derivatives, their methods of preparation, synthesis intermediates and pharmaceutical compositions in which they are present and which are useful especially for the treatment of cardiovascular diseases and duodenal ulcers
PT79610A (en)	1985-01-01	Process for the preparation of pharmaceutical compositions containing basic aluminum sucrose sulfate
FR2634376B1 (fr)	1992-04-17	Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
CA2144676A1 (fr)	1995-09-23	Composition lipophile solide et methode de preparation
CA2171614A1 (fr)	1996-02-01	Composition pharmaceutique contenant des derives d'acide sialique
EP0249736A3 (fr)	1989-03-29	Onguent pour le traitement des maladies de peau
IE880588L (en)	1988-09-03	Synergistic interplay of lymphokines and double-stranded¹RNAs
WO1987000432A3 (fr)	1987-05-21	Compositions contenant de la melatonine ou ses homologues, leurs utilisations pour le traitement du psoriasis vulgaris et/ou des affections apparentees
NO965483L (no)	1997-01-28	Dinukleosid-5',5'-pyrofosfater
CA2142811A1 (fr)	1994-03-03	Methode de preparation d'un nouveau glucane
IL93988A0 (en)	1991-01-31	Substituted 1,8-naphthyridines,their preparation and medicaments comprising them
CA2055257A1 (fr)	1993-03-21	Saccharide comme source d'energie pour un organisme vivant et ses usages
HU9201799D0 (en)	1992-08-28	New 2-amino-5-ciano-1,4-dihydropiridine-derivatives, process for their use and their use as medicaments
CA2150234C (fr)	2001-01-16	Association d'atovaquone et de proguanil pour le traitement d'infection a protozoaires
IL85776A (en)	1992-09-06	Pharmaceutical compositions comprising certain selenium containing algae and c18-c22 unsaturated acids and their preparation,used for treating conditions of the heart and cardiovascular system
FR2612774B1 (fr)	1990-12-28	Compositions cosmetiques et pharmaceutiques, utilisees pour traiter le processus de l'alopecie androgenogenetique, contenant de l'acide azelaique
AU4294496A (en)	1996-07-03	Methods for the preparation of pure homologous series of mono to tetra fatty acyl esters of sugars; characterization of one antitumor component as maltose 1, 6, 6' tripalmitate: and pharmaceutical formulations useful in the treatment of cancer.
IT1265422B1 (it)	1996-11-22	Unguento farmaceutico privo di azione irritativa della pelle e procedimento per la sua preparazione

Legal Events

Date	Code	Title	Description
2000-06-28	EEER	Examination request